Grown Rogue International (GRUSF) Research & Development (2016 - 2020)
Grown Rogue International's (GRUSF) quarterly Research & Development came in at $150.0 in Q3 2020, down 99.68% year-on-year from $47339.0 in Q3 2019, and down 87.95% quarter-over-quarter from $1245.0 in Q1 2020.
Grown Rogue International (GRUSF) Research & Development (2016 - 2020) Analysis & Trends
Grown Rogue International's Research & Development history runs 4 years deep, the most recent figure standing at $150.0 for Q3 2020.
- On a quarterly basis, Research & Development fell 99.68% year-over-year to $150.0 in Q3 2020; TTM through Jul 2020 was $100254.0, a 70.6% decrease from a year earlier, with the FY2018 full-year figure at $5233.0, down 88.0% from the prior year.
- Research & Development retreated to $150.0 in Q3 2020 per GRUSF's latest filing, from $1245.0 in the prior quarter.
- Across five years, Research & Development topped out at $240834.9 in Q3 2017 and bottomed at $150.0 in Q3 2020.
- The 4-year median for Research & Development is $1302.4 (2017), against an average of $42970.7.
- Biggest YoY gain for Research & Development was 97.58% in 2020; the steepest drop was 99.68% in 2020.
- Year by year, Research & Development stood at $658.37 in 2016, then jumped by 36480.64% to $240834.9 in 2017, then plunged by 80.34% to $47339.0 in 2019, then sank by 99.68% to $150.0 in 2020.
- Per Business Quant, the three latest GRUSF Research & Development figures stand at $150.0 (Q3 2020), $1245.0 (Q1 2020), and $47339.0 (Q3 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 138.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Grown Rogue International | 99.32 Mn | 85.61 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2020 | 150.00 |
| Jan 31, 2020 | 1,245.00 |
| Jul 31, 2019 | 47,339.00 |
| Jan 31, 2019 | 51,520.00 |
| Aug 31, 2017 | 240,834.86 |
| May 31, 2017 | 1,359.76 |
| Feb 28, 2017 | 658.79 |
| Nov 30, 2016 | 658.37 |